In summary, the miRNA-34a-5p/ABCC1 axis has positive feedback effects on the sensitivity of MCF-7 and MDA-MB-231 cells to tamoxifen and doxorubicin, respectively, which is expected to be an important target for these chemotherapies in resistant breast cancer progression future studies. This evidence concerns the gene ABCC1 and breast carcinoma.